Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombospondin modulates basic fibroblast growth factor activities on endothelial cells.

G Taraboletti1, D Belotti, R Giavazzi

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.

EXS
|January 1, 1992
PubMed
Summary

Thrombospondin (TSP) inhibits endothelial cell (EC) responses to angiogenic factors like bFGF. This suggests TSP and its fragments play a role in angiogenesis and tumor growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.

British journal of cancer·2023
Same author

Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.

British journal of cancer·2021
Same author

P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival.

Hematology (Amsterdam, Netherlands)·2016
Same author

Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.

Oncogene·2016
Same author

PO-15 - Antiangiogenic small molecule ligands of FGF2 derived from the endogenous inhibitor thrombospondin-1.

Thrombosis research·2016
Same author

PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration.

Thrombosis research·2016

Area of Science:

  • Cell biology
  • Angiogenesis research
  • Biochemistry

Background:

  • Thrombospondin (TSP) is known to induce endothelial cell (EC) adhesion, spreading, and motility.
  • These properties suggest a potential role for TSP in angiogenesis.

Purpose of the Study:

  • To investigate whether TSP modulates EC responses to known angiogenic stimuli in vitro.
  • To determine the specific effects of TSP and its fragments on EC behavior.

Main Methods:

  • In vitro studies using endothelial cells (ECs).
  • Assays to measure EC chemotaxis, proliferation, and response to basic fibroblast growth factor (bFGF) and serum.

Main Results:

  • TSP was found to inhibit the chemotactic response of ECs to bFGF.

Related Experiment Videos

  • TSP and its 140 kD fragment reduced EC proliferation in response to serum and bFGF.

    • Conclusions:

    • TSP and its 140 kD fragment inhibit key endothelial cell functions crucial for angiogenesis.
    • These findings support a role for TSP in angiogenesis and associated pathologies, such as tumor malignancy.